Get App Open
In App
Lending
Lending
Open App
you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 30, 16:01
1619.20 -8.55 (-0.53%)
Volume
AVERAGE VOLUME
5-Day
14,297
10-Day
12,305
30-Day
34,495
1,365
  • Prev. Close

    1627.75

  • Open Price

    1623.00

  • Bid Price (Qty.)

    1602.55 (1)

  • Offer Price (Qty.)

    1638.00 (54)

NSE Live

Oct 30, 15:48
1619.90 -9.70 (-0.60%)
Volume
AVERAGE VOLUME
5-Day
249,268
10-Day
212,591
30-Day
244,631
289,492
  • Prev. Close

    1629.60

  • Open Price

    1629.80

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1619.90 (68)

Financials

Key Financial Ratios of Eris Lifesciences (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
Per Share Ratios  
Basic EPS (Rs.) 5.69 22.04 29.27 30.70 25.82  
Diluted EPS (Rs.) 5.68 22.01 29.23 30.70 25.80  
Cash EPS (Rs.) 19.03 29.56 34.02 34.48 28.59  
Book Value [ExclRevalReserve]/Share (Rs.) 184.65 185.55 163.39 141.11 116.03  
Book Value [InclRevalReserve]/Share (Rs.) 184.65 185.55 163.39 141.11 116.03  
Dividend / Share(Rs.) 7.35 0.00 7.35 6.01 5.50  
Revenue from Operations/Share (Rs.) 124.65 109.29 97.85 89.44 81.66  
PBDIT/Share (Rs.) 38.33 35.92 38.41 37.74 31.47  
PBIT/Share (Rs.) 24.98 28.39 33.66 33.95 28.70  
PBT/Share (Rs.) 8.81 24.17 32.13 33.73 28.64  
Net Profit/Share (Rs.) 5.68 22.03 29.27 30.69 25.82  
Profitability Ratios  
PBDIT Margin (%) 30.75 32.86 39.25 42.19 38.53  
PBIT Margin (%) 20.04 25.98 34.39 37.96 35.14  
PBT Margin (%) 7.07 22.11 32.83 37.71 35.07  
Net Profit Margin (%) 4.55 20.15 29.90 34.31 31.61  
Return on Networth / Equity (%) 3.07 11.87 17.91 21.75 22.25  
Return on Capital Employed (%) 8.04 12.50 18.30 23.26 24.19  
Return on Assets (%) 1.48 5.60 14.29 19.40 19.97  
Total Debt/Equity (X) 0.88 1.00 0.14 0.00 0.00  
Asset Turnover Ratio (%) 0.32 0.37 0.54 0.62 63.18  
Liquidity Ratios  
Current Ratio (X) 0.63 0.83 1.95 3.49 2.93  
Quick Ratio (X) 0.44 0.79 1.72 2.98 2.48  
Inventory Turnover Ratio (X) 0.48 1.24 1.54 1.57 17.10  
Dividend Payout Ratio (NP) (%) 129.29 0.00 25.10 19.57 21.30  
Dividend Payout Ratio (CP) (%) 38.60 0.00 21.59 17.42 19.23  
Earnings Retention Ratio (%) -29.29 0.00 74.90 80.43 78.70  
Cash Earnings Retention Ratio (%) 61.40 0.00 78.41 82.58 80.77  
Valuation Ratios  
Enterprise Value (Cr.) 21,413.22 12,675.55 8,048.53 9,320.83 8,174.56  
EV/Net Operating Revenue (X) 12.61 8.53 6.05 7.67 7.37  
EV/EBITDA (X) 41.02 25.94 15.41 18.17 19.13  
MarketCap/Net Operating Revenue (X) 11.36 7.70 5.85 7.70 7.40  
Retention Ratios (%) -29.29 0.00 74.89 80.42 78.69  
Price/BV (X) 7.67 4.53 3.50 4.88 5.21  
Price/Net Operating Revenue 11.36 7.70 5.85 7.70 7.40  
Earnings Yield 0.00 0.03 0.05 0.04 0.04  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347